UsAgainstAlzheimer’s Launches Online Biomarkers Repository to Track Alzheimer’s Research

In an important step to advance Alzheimer’s research, UsAgainstAlzheimer’s today announced the creation of a new online Biomarkers Repository to track research into Alzheimer’s biomarkers and diagnostics. The constantly-evolving Biomarkers Repository will help policymakers, healthcare system leaders and scientific community better understand and support personalized medicine.

The prescription for an effective treatment or cure for Alzheimer’s: More research and cautious optimism

It’s been an exciting few weeks in the Alzheimer’s world – a world that hasn’t seen a new drug in 15 years. All of the activity has raised a lot of questions around the world’s progress toward a cure.

It’s time to pick up the pace on Alzheimer’s prevention

Milken Institute report urges our nation to double down on efforts to reduce the cost and risk of dementia and outlines a series of recommended action steps.

Four Leading Alzheimer’s Organizations Agree on Need For National, Time-Based Prevention Goal

Director of the National Center for Chronic Disease Prevention and Health Promotion, Senior Director of Center for the Future of Aging, and Leading U.S. Alzheimer’s Researcher Resoundingly Support UsAgainstAlzheimer’s Call for a Time-based Alzheimer’s Prevention Goal

UsAgainstAlzheimer’s Applauds Positive News on Alzheimer’s Drug Aducanumab

Statement from George Vradenburg on the announcement by Biogen and Eisai of plans to seek regulatory approval in early 2020 by the Food and Drug Administration (FDA) for aducanumab, an investigational treatment for early Alzheimer’s disease.

New Study Highlights Need for Healthcare Providers to Engage Alzheimer’s Caregivers

A new study from UsAgainstAlzheimer's and Mayo Clinic spotlights the often-overlooked need for family caregivers of people with Alzheimer’s disease to be more engaged by physicians during medical appointments with their loved ones.

New Biomarkers Repository

More research and cautious optimism

Reducing Cost and Risk

National Prevention Goal

Aducanumab Reversal

Engaging Family Caregivers

  • A Letter from Our Chairman

    UsAgainstAlzheimer’s Brain Health Partnership has issued a Call to Action white paper outlining recommendations for building a better system of care to promote brain health and fight back against Alzheimer’s.

Read the Letter

We Are Committed to Stopping Alzheimer's by 2020.

  • Blog Post
    Thumbnail

    “A Devil of a Disease”: The Current Alzheimer’s Pipeline

    This article was originally published by BioSpace on August 7, 2019.

    By Mark Terry

    As anyone following Alzheimer’s research knows, drug development for the disease has been a wasteland of failed

    Read more
  • Blog Post
    Thumbnail

    My Birthday Wish

    My name is Andres Martin and this week I turned 32 years old.  I’m a proud father, husband, and veteran. Over the last couple of years, I’ve come to recognize

    Read more
  • Welcome to the New Era of Alzheimer’s Research: How People with Alzheimer’s and Care Partners are Shaping the Future of Drug Development

    This article was originally published by Lundbeck on July 17, 2019.

    By Mark Terry

    Leigh Callahan, PhD, is a respected epidemiologist and outcomes researcher who focuses on rheumatic disease. Her husband,

    Read more

The Pulse of the Community: Volume 4, Fall 2019

The A-LIST transforms the stories of more than 8,000 people living with Alzheimer’s or other dementias into evidence-based insights by providing unique, rapid-response, self-reported data through virtual surveys on what matters most on a wide range of Alzheimer’s-related topics. The A-LIST offers a powerful and validating voice for those living with Alzheimer’s and those caring for them, and a pathway to help expand treatments and accelerate toward a cure.